Geode Capital Management »

Mymd Pharmaceuticals shares owned by Geode Capital Management

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 16k 1.62
2024-06-30 $27k 14k 1.84

More positions owned by Geode Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)
Visa Inc-class A Shares Com Cl A (V)

View all positions for Geode Capital Management

Top funds holding Mymd Pharmaceuticals

Geode Capital Management
Vanguard Group
Virtu Financial
BlackRock
BlackRock
Parallel Advisors
Group One Trading
Morgan Stanley
Wells Fargo & Company
Sandy Spring Bank
Advisor Group Holdings
Harbor Investment Advisory
Royal Bank of Canada
Tower Research Capital
ORG Wealth Partners

View all funds holding Mymd Pharmaceuticals